Dr. Amir Bajoghli and Skin & Laser Dermatology Center are excited to introduce advanced laser treatments for telangiectasia, offering patients effective solutions to reduce the appearance of small, ...

Dave Coulier shared an update about his cancer treatment on the latest episode of his "Full House Rewind" podcast.

Ouro Medicines, a biotechnology company developing immune reset therapeutics for people living with chronic immune-mediated diseases, today announced its launch with $120 million in funding. The ...

NEW YORK (PIX11) — A young man, homeless and disheveled, was surrounded by a joint response team made up of two NYPD officers ...

Botulinum toxin (BTX), widely known for its cosmetic and neurological applications, is emerging as a potential treatment for ...

Highly Positive Clinical Data on Completion of Testing for First Subject Dosed Twice Daily with QRX003 in Open-Label Study ...

Ianalumab is under clinical development by Novartis and currently in Phase II for Systemic Sclerosis (Scleroderma).

Brentuximab vedotin is under clinical development by Pfizer and currently in Phase II for Systemic Sclerosis (Scleroderma). According to GlobalData, Phase II drugs for Systemic Sclerosis (Scleroderma) ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...

If you or a loved one is struggling with anxiety or depression, contact the Substance Abuse and Mental Health Services Administration (SAMHSA) National Helpline at 800-662-4357 for information on ...

Lower back pain can affect one's ability to move comfortably and function throughout the day. Medications, including over-the-counter (OTC) and prescription drugs, are available to manage pain and ...